Small Pharma
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United KingdomWebsite
www.smallpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Small Pharma
Cybin is a leading ethical biopharmaceutical company focused on developing safe and effective therapeutics for mental health issues. The company collaborates with world-class partners and scientists to create innovative drug delivery systems and proprietary drug discovery platforms. Cybin's pipeline includes novel therapies targeting Major Depressive Disorder and Generalized Anxiety Disorder, utilizing tryptamine-based compounds. With a strong emphasis on scientific leadership and regulatory expertise, Cybin aims to revolutionize mental healthcare.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Small Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Small Pharma had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Small Pharma
Earning: See what the market has to say on Small Pharma recently announced quarterly report
Small Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Small Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Small Pharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Small Pharma launches new products
Funding: Get notified immidiatlly once Small Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Small Pharma
Compare insights from companies similar to Small Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Small Pharma
<$5M
11-50
Private
-
2015
N/A
Company Profile Activity
Activity Insights
Small Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Small Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Small Pharma.
Small Pharma Tech Stack
A closer look at the technologies used by Small Pharma
See more technologies
Small Pharma News & Media
Small Pharma Obtains Final Order Approving Arrangement
LONDON & TORONTO--(BUSINESS WIRE)--Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (“Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions and Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, are pleased to announce that Small Pharma has obtained a final order of tSmall Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, commends Small Pharma Inc. (“Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, on its positive safety, tolerability and efficacy data from its Phase Ib study exploriCybin to Buy Small Pharma
Cybin Inc. (NYSE American:CYBN) (NEO:CYBN), a clinical-stage biopharmaceutical company developing new and innovative psychedelic-based treatment options, acquired Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF), a U.K.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions. It is currently expected that the transaction will close in late October 2023. The combined company will remain headquartered in […] The post Cybin to Buy Small Pharma appeared firCybin to Acquire Small Pharma Inc.
TORONTO & LONDON--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) (“Small Pharma”), a U.K.-based biotechnology company focused on short-duration psychedelic therapies for mental health conditions, today announced that they have entered into a definitive arrangement agr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Small Pharma
Sign Up For FreeTo access detailed company insights
Cybin is a leading ethical biopharmaceutical company focused on developing safe and effective therapeutics for mental health issues. The company collaborates with world-class partners and scientists to create innovative drug delivery systems and proprietary drug discovery platforms. Cybin's pipeline includes novel therapies targeting Major Depressi... Read More
